SPOTLIGHT -
Efficacy of Onapristone in PR-Expressing Tumors
Alexander Zukiwski, MD, CEO, Arno Therapeutics, Inc., discusses the efficacy of onapristone (ONA) in progesterone receptor (PR)-expressing tumors.
